Metropolitan Life Insurance CO Atea Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.09 - $4.56 $1,285 - $1,896	416 Added 18.93%	2,613 $10,000
Q4 2023 Feb 14, 2024	SELL	$2.8 - $3.35 $6,666 - $7,976	-2,381 Reduced 52.01%	2,197 $6,000
Q2 2023 Aug 10, 2023	BUY	$3.21 - $5.06 $14,695 - $23,164	4,578 New	4,578 $17,000
Q4 2022 Jun 14, 2023	BUY	$4.35 - $6.17 $21,436 - $30,405	4,928 New	4,928 $23.7 Million
Q3 2022 Jun 14, 2023	BUY	$5.49 - $8.79 $27,054 - $43,317	4,928 New	4,928 $28 Million
Q2 2022 Jun 20, 2023	BUY	$5.33 - $8.18 $26,266 - $40,311	4,928 New	4,928 $34,000
Q1 2022 Jun 20, 2023	BUY	$5.5 - $9.19 $27,104 - $45,288	4,928 New	4,928 $35,000
Q1 2022 Mar 30, 2023	SELL	$5.5 - $9.19 $76,686 - $128,136	-13,943 Reduced 73.89%	4,928 $35,000
Q1 2022 May 12, 2022	SELL	$5.5 - $9.19 $76,686 - $128,136	-13,943 Reduced 73.89%	4,928 $36,000
Q4 2021 Jun 21, 2023	BUY	$7.67 - $44.59 $144,740 - $841,457	18,871 New	18,871 $168,000
Q3 2021 Jun 21, 2023	BUY	$21.33 - $35.06 $402,518 - $661,617	18,871 New	18,871 $661,000
Q2 2021 Mar 30, 2023	BUY	$19.22 - $59.08 $273,885 - $841,890	14,250 Added 308.37%	18,871 $405,000
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $362,604 - $1.11 Million	18,866 Added 377320.0%	18,871 $405,000
Q1 2021 Jun 26, 2023	BUY	$41.42 - $88.44 $191,401 - $408,681	4,621 New	4,621 $285 Million
Q1 2021 Mar 30, 2023	SELL	$41.42 - $88.44 $9,360 - $19,987	-226 Reduced 4.66%	4,621 $285,000
Q1 2021 May 14, 2021	SELL	$41.42 - $88.44 $200,555 - $428,226	-4,842 Reduced 99.9%	5 $285,000
Q4 2020 Jun 22, 2023	BUY	$26.36 - $41.78 $127,766 - $202,507	4,847 New	4,847 $202,000
Q4 2020 Mar 30, 2023	SELL	$26.36 - $41.78 $2,135 - $3,384	-81 Reduced 1.64%	4,847 $202,000
Q4 2020 Feb 16, 2021	BUY	$26.36 - $41.78 $127,766 - $202,507	4,847 New	4,847 $203,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

Black Rock Inc. New York, NY

9.12M
Shares

$30.1 Million
0.0% of portfolio
Bml Capital Management, LLC Zionsville, IN

6.65M
Shares

$21.9 Million
13.11% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.44M
Shares

$18 Million
0.79% of portfolio
Vanguard Group Inc Valley Forge, PA

4.85M
Shares

$16 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

4.61M
Shares

$15.2 Million
1.31% of portfolio

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $275M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account